Summit Therapeutics
SMMT
$3.86
Share price
8.73%
Change (1 day)
192.42%
Change (1 year)
Categories
EPS for Summit Therapeutics (SMMT)
EPS in 2023 (TTM): -$1.68
According to Summit Therapeutics 's latest financial reports the company's current EPS (TTM) is -$1.68. In 2022 the company made an earnings per share (EPS) of -$0.50 an increase over its 2021 EPS that were of -$0.96.
EPS history for Summit Therapeutics from 2015 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$1.68 | 235.49% |
| 2022 | -$0.50 | -47.8% |
| 2021 | -$0.96 | |
| 2019 | -$0.21 | 159.55% |
| 2018 | -$0.08171 | |
| 2015 | -$0.69 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | -$7.83 | 365.77% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | -$0.11 | -93.46% | 🇺🇸 USA |
 Coherus BioSciences
CHRS | -$3.32 | 97.49% | 🇺🇸 USA |